Recent Updates
Recently added Catalysts
QGEN Positive Sentiment

QIAGEN Calls Extraordinary General Meeting for Appointment of Jonathan M. Pratt to Managing Board

Key Takeaway: QIAGEN N.V. has scheduled an Extraordinary General Meeting for November 6, 2026, to vote on the appointment of Jonathan M. Pratt to its Managing Board. Pratt, who joined as CEO on September 1, 2026, will potentially join CFO Roland Sackers on the board. This meeting highlights QIAGEN's commitment to shareholder involvement.

Market Sentiment Analysis

POSITIVE FACTORS

  • Appointment of a new CEO indicates growth and leadership change.
  • Extraordinary General Meeting allows shareholders to participate in decision-making.
  • Jonathan M. Pratt's leadership may bring fresh perspectives to QIAGEN.

Full Press Release Details

VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it will hold an Extraordinary General Meeting of Shareholders on November 6, 2026, at 2:00 p.m. CET. Shareholders will be asked to vote on the appointment of Jonathan M. Pratt to the QIAGEN Managing Board after he joined QIAGEN as Chief Executive Officer on September 1, 2026. Subject to shareholder approval, Jon Pratt would join Roland Sackers, Chief Financial Officer, as the two me

Frequently Asked Questions

When is the Extraordinary General Meeting for QIAGEN?

The Extraordinary General Meeting is scheduled for November 6, 2026.

Who is being appointed to the QIAGEN Managing Board?

Jonathan M. Pratt is being proposed for appointment to the Managing Board.

What role did Jonathan M. Pratt assume at QIAGEN?

Jonathan M. Pratt joined QIAGEN as Chief Executive Officer on September 1, 2026.

Who else is on the QIAGEN Managing Board?

Roland Sackers serves as the Chief Financial Officer on the Managing Board.

Last updated: Sep 18, 2026